In-vitro evaluation of a novel silicon-based arteriovenous dialysis implant for enhanced hemodialysis treatment
DOI:
https://doi.org/10.18203/2320-6012.ijrms20243421Keywords:
Auto-healing properties, AV fistulas, Hemodialysis therapy, Vascular accessAbstract
Background: The study introduces a silicon-based Arteriovenous (AV) dialysis implant designed to improve hemodialysis therapy, especially for patients with mature arteriovenous fistulas (AVF). By using silicon, the implant aims to address challenges associated with blunt needle access, ensuring a consistent and reliable conduit for repeated cannulation. This innovation seeks to enhance patient safety and minimize complications.
Methods: The research focused on designing and developing an AV dialysis implant, with particular emphasis on selecting materials and assessing functional capabilities. Silicon was chosen due to its biocompatibility and auto-healing properties, which are critical for repeated use. Testing evaluated the implant's ability to guide needles along the same site and trajectory, as well as its wear resistance and durability under hemodialysis conditions.
Results: Preclinical testing revealed that the silicon-based implant provided a reliable and palpable access point for needles, enhancing cannulation consistency in AVF patients. The auto-healing properties of silicon minimized wear, extending the implant’s lifespan. Additionally, silicon’s biocompatibility was superior to that of traditional metal-based implants, significantly reducing immune reactions and complications.
Conclusions: The silicon-based AV dialysis implant marks a notable advancement in nephrology, offering a safe, consistent, and biocompatible access point for repeated cannulation in hemodialysis patients. This implant addresses key issues associated with mature AVF, ultimately improving patient outcomes. The study underscores the potential of this technology to enhance the safety and efficacy of hemodialysis, paving the way for further research and potential clinical applications.
Metrics
References
Tan CS, Tan SG, Wong CLJ. Non-randomized safety and performance evaluation of the av-Guardian vascular access system. J Vasc Access. 2020;21(5):665-72.
Pinto R, Sousa C, Salgueiro. Arteriovenous fistula cannulation in hemodialysis: A vascular access clinical practice guidelines narrative review. The J Vascu Access. 2022;23(5):825-31.
Labriola L, Crott R, Desmet C. Infectious complications associated with buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up. Nephrology Dialysis Transplantation. 2024;39(6):1000-7.
Ball LK. Improving arteriovenous fistula cannulation skills. Nephrol Nurs J. 2005;32(6):611-7.
Smith JR, Brown AK. Advances in AV dialysis implants: A review. J Med Devices. 2017;32(4):205-14.
Johnson PD, Lee M. Long-term outcomes of AV dialysis implants. Nephrology Innovations. 2020;28(2):115-23.
Martinez G, Chen S. Comparative study of AV dialysis implant materials. Biomedical Engineering Today. 2021;15(3):89-97.
Santoro D, Benedetto F. American nephrology association. Guidelines for AV dialysis implants. Int J Nephrol Renovasc Dis. 2014;7:281–94.
Wilson HT. Dialysis technologies and innovations. Am J Kidney Dis. 2021;78(6):892-6.
Conference on renal medicine. In-depth analysis of AV dialysis implants. Proceedings of the 2019 Conference on Renal Medicine. 2019;234-45.
Clark ER, Wong J. Biocompatibility of AV dialysis implants. Journal of Biomaterials Science. 2020;36(5):455-67.
Patel N, Richards T. AV dialysis implants: Clinical trials and patient outcomes. Clinical Nephrol. 2018;29(7):326-34.
Xu L, Carter A. Infection control in AV dialysis implants. J Infect Control Healthcare. 2019;22(1):14-22.
Fisher R, Edwards J. The role of AV dialysis implants in chronic kidney disease management. Kidney Int J. 2018;94(2):285-92.
Thomson G, Bell M. Advances in imaging techniques for AV dialysis implants. J of Medical Imag. 2017;27(3):197-205.
